| NCT ID | NCT04884620 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rigshospitalet, Denmark |
| Condition | Puberty |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2023-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The COPENHAGEN School Study is a combined cross-sectional and longitudinal study of healthy Danish school children. This study will by clinical examinations and withdrawal of blood samples investigate whether age of pubertal onset is continuing to decline in Denmark over the past 15 years. Furthermore, we will investigate the mechanism driving earlier onset of puberty and the long term health risks of extremely early puberty using Danish registry data
Eligibility Criteria
Inclusion Criteria: * Healthy children and adolescents Exclusion Criteria: * In case of acute disease, cancer, cancer therapy, or chronic disease (History of malignant disease, chemotherapy or radiation, cystic fibrosis, juvenile rheumatoid arthritis, systemic lupus erythematosus, sickle cell disease, thalassemia, chronic renal disease or known numerical chromosome aberration) * Non-Caucasian
Contact & Investigator
Anders Juul, PhD, DMSc
PRINCIPAL INVESTIGATOR
Rigshospitalet, Department of Growth and Reproduction
Frequently Asked Questions
Who can join the NCT04884620 clinical trial?
This trial is open to participants of all sexes, aged 5 Years or older, up to 19 Years, studying Puberty. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04884620 currently recruiting?
Yes, NCT04884620 is actively recruiting participants. Contact the research team at anders.juul@regionh.dk for enrollment information.
Where is the NCT04884620 trial being conducted?
This trial is being conducted at Copenhagen, Denmark.
Who is sponsoring the NCT04884620 clinical trial?
NCT04884620 is sponsored by Rigshospitalet, Denmark. The principal investigator is Anders Juul, PhD, DMSc at Rigshospitalet, Department of Growth and Reproduction. The trial plans to enroll 3,000 participants.